These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 17497328)
1. Comment on: incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab. Errante D; Bernardi D; Bianco A; Salvagno L Acta Oncol; 2007; 46(4):565-6. PubMed ID: 17497328 [No Abstract] [Full Text] [Related]
2. Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab. Yau T; Swanton C; Chua S; Sue A; Walsh G; Rostom A; Johnston SR; O'Brien ME; Smith IE Acta Oncol; 2006; 45(2):196-201. PubMed ID: 16546866 [TBL] [Abstract][Full Text] [Related]
3. Rationale for the use of trastuzumab in patients with cerebral metastases who previously receive trastuzumab-based therapy for metastatic breast cancer. Altundag K; Altundag O; Atik MA; Morandi P; Gunduz M Breast; 2005 Oct; 14(5):425. PubMed ID: 16216749 [No Abstract] [Full Text] [Related]
4. Brain metastases in patients receiving trastuzumab for breast cancer. Errante D; Bernardi D; Bianco A; Salvagno L Neurol Sci; 2007 Mar; 28(1):52-3. PubMed ID: 17385098 [No Abstract] [Full Text] [Related]
5. Brain metastases in patients receiving trastuzumab for breast cancer. Salmaggi A; Silvani A; Boiardi A Neurol Sci; 2007 Mar; 28(1):1. PubMed ID: 17385088 [No Abstract] [Full Text] [Related]
6. Clinical utility of continuing trastuzumab beyond brain progression in HER-2 positive metastatic breast cancer. Metro G; Sperduti I; Russillo M; Milella M; Cognetti F; Fabi A Oncologist; 2007 Dec; 12(12):1467-9; author reply 1469-71. PubMed ID: 18165625 [No Abstract] [Full Text] [Related]
7. Survival after brain metastases from breast cancer in the trastuzumab era. Kirsch DG; Ledezma CJ; Mathews CS; Bhan AK; Ancukiewicz M; Hochberg FH; Loeffler JS J Clin Oncol; 2005 Mar; 23(9):2114-6; author reply 2116-7. PubMed ID: 15774813 [No Abstract] [Full Text] [Related]
8. Treatment of brain metastases in patients with HER2+ breast cancer. Bravo Marques JM Adv Ther; 2009 Jul; 26 Suppl 1():S18-26. PubMed ID: 19669638 [TBL] [Abstract][Full Text] [Related]
9. Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier. Stemmler HJ; Schmitt M; Willems A; Bernhard H; Harbeck N; Heinemann V Anticancer Drugs; 2007 Jan; 18(1):23-8. PubMed ID: 17159499 [TBL] [Abstract][Full Text] [Related]
10. Incidence of brain metastases in early stage HER2 3+ breast cancer patients; is there a role for brain CT in asymptomatic patients? Tomasevic ZI; Rakocevic Z; Tomasevic ZM; Milovanovic Z; Inic M; Kolarevic D; Lukic V; Kovac Z J BUON; 2012; 17(2):249-53. PubMed ID: 22740201 [TBL] [Abstract][Full Text] [Related]
11. [Brain metastases in breast cancer: a special disease course for HER2 positive tumors]. Hurkens KP; Hupperets PS; Creemers GJ; Erdkamp FL; van de Vijver KK; Tjan-Heijnen VC Ned Tijdschr Geneeskd; 2008 Dec; 152(50):2701-6. PubMed ID: 19192581 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapy in breast cancer patients with brain metastases: have new chemotherapic agents changed the clinical outcome? Tosoni A; Franceschi E; Brandes AA Crit Rev Oncol Hematol; 2008 Dec; 68(3):212-21. PubMed ID: 18550383 [TBL] [Abstract][Full Text] [Related]
13. Extended survival in women with brain metastases from HER2 overexpressing breast cancer. Church DN; Modgil R; Guglani S; Bahl A; Hopkins K; Braybrooke JP; Blair P; Price CG Am J Clin Oncol; 2008 Jun; 31(3):250-4. PubMed ID: 18525303 [TBL] [Abstract][Full Text] [Related]
14. Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Bendell JC; Domchek SM; Burstein HJ; Harris L; Younger J; Kuter I; Bunnell C; Rue M; Gelman R; Winer E Cancer; 2003 Jun; 97(12):2972-7. PubMed ID: 12784331 [TBL] [Abstract][Full Text] [Related]
15. Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab. Montagna E; Cancello G; D'Agostino D; Lauria R; Forestieri V; Esposito A; Silvestro L; Accurso A; De Placido S; De Laurentiis M Cancer Chemother Pharmacol; 2009 Jan; 63(2):275-80. PubMed ID: 18379783 [TBL] [Abstract][Full Text] [Related]
16. Cerebral metastases in patients with advanced breast cancer treated with trastuzumab. Atkinson J; Peace J; Crawford SM Am J Clin Oncol; 2004 Apr; 27(2):212. PubMed ID: 15057165 [No Abstract] [Full Text] [Related]
17. The effect of early detection of occult brain metastases in HER2-positive breast cancer patients on survival and cause of death. NiwiĆska A; Tacikowska M; Murawska M Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1134-9. PubMed ID: 19932944 [TBL] [Abstract][Full Text] [Related]
18. Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer. Stemmler HJ; Kahlert S; Siekiera W; Untch M; Heinrich B; Heinemann V Breast; 2006 Apr; 15(2):219-25. PubMed ID: 16026983 [TBL] [Abstract][Full Text] [Related]
19. Trastuzumab in CNS progressive metastatic breast cancer. Tosoni A; Franceschi E; Esposti RD; Brandes AA Future Oncol; 2007 Aug; 3(4):367-9. PubMed ID: 17661709 [No Abstract] [Full Text] [Related]
20. The incidence and treatment outcome after radiotherapy for brain metastases in HER-2-positive metastatic breast cancer patients treated with trastuzumab. Arif S; Barrett-Lee PJ; Jordan C Clin Oncol (R Coll Radiol); 2006 Nov; 18(9):719-20. PubMed ID: 17100160 [No Abstract] [Full Text] [Related] [Next] [New Search]